Martin Shkreli (above) is a former hedge fund manager and the current CEO of Turing Pharmaceuticals. In August Shkreli bought a drug called Daraprim. It's been around for 62 years and is used to treat toxoplasmosis, a life-threatening parasitic infection. "Turing immediately raised the price to $750 a tablet from $13.50, bringing the annual cost of treatment for some patients to hundreds of thousands of dollars," reports the New York Times.
It's fun to single out Shkreli for his questionable ethics, but plenty of other pharmaceutical companies also jack up the the price of formerly cheap drugs to levels that will bankrupt people who need them. The antibiotic Doxycycline was $20 a bottle in 2013. Today, the same bottle costs $1,849. Cycloserine, a tuberculosis treatment, used to cost $500 for a 30 pill bottle, until Rodelis Therapeutics acquired the drug and increased the price to $10,800.
As seen by his tweet last night, Shkreli's response to the overwhelmingly negative reaction to his price increase is basically "fuck you."
Watch Bloomberg's interview with Shkreli about his decision to raise the price. He admits it costs less than $1 a pill to manufacture Daraprim, yet insists at $750 a pill, "Daraprim is still underpriced relative to its peers."
Donald Trump has insisted that Plaquenil/hydroxychloroquine will cure COVID-19. The drug is commonly used to malaria, as well as lupus and rheumatoid arthritis. While there have been some successful results with drug after treating patients infected by the novel coronavirus, there’s just not enough reliable information available right now. But the President’s endorsement of the […]
The head of the pharmaceutical company that makes EpiPens raised the price of the life-saving device by over 400%. She was rewarded with a 671% raise.
Yesterday, former hedge fund manager Martin Shkreli (above) was in the news for jacking up the price of a drug called Daraprim from $13.50 per tablet to $750 per tablet. He went on Bloomberg to explain why he thinks a pill that costs less than $1 to manufacture should cost $750. He said that even […]
When you were 10 and your mom demanded you finish your vegetables or go to your room, you were mad. Even as kids, we hated it when we were ordered to do something. Car insurance is a federal mandate, yet that’s only one of the reasons why most Americans would rather do just about anything […]
We all know the drill. As the overlords of the smartphone and tablet markets, the braintrust at Apple very seldom hold sales on their signature devices. So rather than spending almost $1,000 on a brand-new iPad Pro, the folks in Cupertino are instead giving you the opportunity to score one for about a third of […]
Entrepreneurs looking for new avenues to reach customers may not have considered one of the fastest-growing content mediums today: podcasting. And we don’t mean just dropping an advertisement for your product or service in the middle of a popular show. Right now, there are about 850,000 active podcasts reaching 165 million Americans. Those listeners are […]